Ringpu Bio completes acquisition of Tianjin Zhongrui stake

Ringpu Bio (SZSE:300119) has finalized its acquisition of a 56.3129% stake in Tianjin Zhongrui Supply Chain Management Co., Ltd. from Ruipai Pet Hospital Management Co., Ltd. for 103.62 million yuan. The transaction, initially approved on December 12, 2024, increases Ringpu Bio's ownership in Zhongrui and was funded through internal resources and financing. Post-acquisition, Ruipai Pet Hospital Management's stake decreases to 30%, while Ringpu Bio becomes the majority shareholder. The deal involved the transfer of 61.82 million yuan worth of registered capital. Additionally, Ringpu Bio confirmed related party transactions with Ruipai Pet Hospital totaling 114.07 million yuan in 2024, primarily for product sales and service provisions.